Mucinous colorectal adenocarcinoma: clinical pathology and treatment options

C Luo, S Cen, G Ding, W Wu - Cancer communications, 2019 - Springer
Mucinous colorectal adenocarcinoma is a distinct subtype of colorectal cancer (CRC)
characterized by the presence of abundant extracellular mucin which accounts for at least …

Tumor microenvironment in metastatic colorectal cancer: the arbitrator in patients' outcome

C Galindo-Pumariño, M Collado, M Herrera, C Peña - Cancers, 2021 - mdpi.com
Simple Summary Colorectal cancer accounts for approximately 10% of all annually
diagnosed cancers worldwide being liver metastasis, the most common cause of death in …

The vascular landscape of human cancer

BM Kahn, A Lucas, RG Alur… - The Journal of …, 2021 - Am Soc Clin Investig
Tumors depend on a blood supply to deliver oxygen and nutrients, making tumor
vasculature an attractive anticancer target. However, only a fraction of patients with cancer …

The prognostic value of hypoxia-inducible factor-1α in advanced cancer survivors: a meta-analysis with trial sequential analysis

S Han, T Huang, F Hou, L Yao… - … Advances in Medical …, 2019 - journals.sagepub.com
Background: Expression of hypoxia-inducible factors (HIFs) has been observed, but their
prognostic role in advanced cancers remains uncertain. We conducted a meta-analysis to …

HypoxaMIRs: key regulators of hallmarks of colorectal cancer

J Coronel-Hernández, I Delgado-Waldo… - Cells, 2022 - mdpi.com
Hypoxia in cancer is a thoroughly studied phenomenon, and the logical cause of the
reduction in oxygen tension is tumor growth itself. While sustained hypoxia leads to death by …

B7-H3 at the crossroads between tumor plasticity and colorectal cancer progression: a potential target for therapeutic intervention

E Varghese, SM Samuel, A Brockmueller… - Cancer and Metastasis …, 2024 - Springer
Abstract B7-H3 (B7 homology 3 protein) is an important transmembrane immunoregulatory
protein expressed in immune cells, antigen-presenting cells, and tumor cells. Studies reveal …

Angiogenesis in primary colorectal cancer and matched metastatic tissues: Biological and clinical implications for anti‑angiogenic therapies

L Yin, J Li, D Ma, D Li, Y Sun - Oncology Letters, 2020 - spandidos-publications.com
Metastasis remains a notable issue in patients with newly diagnosed colorectal carcinomas
(CRC). Although anti‑angiogenic therapies target metastatic diseases, hypoxia‑inducible …

Circulating VEGF and eNOS variations as predictors of outcome in metastatic colorectal cancer patients receiving bevacizumab

G Marisi, E Scarpi, A Passardi, O Nanni, A Ragazzini… - Scientific reports, 2017 - nature.com
Novel predictive biomarkers are needed to improve patient selection and optimize the use of
bevacizumab (B) in metastatic colorectal cancer. We analyzed the potential of five circulating …

Clinicopathologic and prognostic significance of immunohistochemical expression of HIF-1α, CXCR4 and CA9 in colorectal carcinoma

B Saka, O Ekinci, A Dursun, N Akyurek - Pathology-Research and Practice, 2017 - Elsevier
Objective To investigate the immunohistochemical expressions of HIF-1α, CA9 and CXCR4
in resected human CRC specimens in relation to clinicopathologic and prognostic variables …

Prognostic Values of Tissue and Serum Angiogenic Growth Factors Depend on the Phenotypic Subtypes of Colorectal Cancer

JH Kasurinen, J Hagström, T Kaprio, S Jalkanen… - Cancers, 2023 - mdpi.com
Simple Summary In this study, we showed that the prognostic value of serum concentrations
and the tissue expressions of angiogenic growth factors VEGF, bFGF, and PDGF-bb vary …